Kalkine has a fully transformed New Avatar.
Neuren Pharmaceuticals Limited (ASX:NEU) is an ASX-listed biopharmaceutical company, focusing on the development and commercialisation of novel treatments for neurological disorders. The company is making significant progress with its lead products, DAYBUE™ (trofinetide) and NNZ-2591.
Highlights
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine! Start Your 7-Days Free Trial Today!
Continue